DR ANTHONY MELVIN CRASTO,WorldDrugTracker, helping millions, A 90 % paralysed man in action for you, I am suffering from transverse mylitis and bound to a wheel chair, With death on the horizon, nothing will not stop me except God................DR ANTHONY MELVIN CRASTO Ph.D ( ICT, Mumbai) , INDIA 25Yrs Exp. in the feld of Organic Chemistry,Working for GLENMARK GENERICS at Navi Mumbai, INDIA. Serving chemists around the world. Helping them with websites on Chemistry.Million hits on google, world acclamation from industry, academia, drug authorities for websites, blogs and educational contribution
Showing posts with label 4-(trans-2-((R)-2-methylpiperazine-1 -carbonyl)cyclopropyl)benzamide. Show all posts
Showing posts with label 4-(trans-2-((R)-2-methylpiperazine-1 -carbonyl)cyclopropyl)benzamide. Show all posts

Saturday, 17 January 2015

4-(trans-2-((R)-2-methylpiperazine-1 -carbonyl)cyclopropyl)benzamide

4-(trans-2-((R)-2-methylpiperazine-1 -carbonyl)cyclopropyl)benzamide
Figure imgf000037_0001
Intermediate B (849 mg, 2.19 mmol) was dissolved in DCM (10.0 mL). TFA
(5.00 mL) was added and the reaction mixture stirred at rt for 30 min. Volatiles were evaporated under reduced pressure to give a yellow gum. The crude material was used in the next step without purification. 

1H NMR (400 MHz, CD3OD) δ ppm 1 .33 (d, J=7.03 Hz, 3H) 1 .37-1 .52 (m, 3 H) 1 .65 (br. s., 1 H) 2.26-2.39 (m, 1 H) 2.51 (br. s., 1 H ) 3.1 1 (br. s., 1 H) 3.21 -3.45 (m, 4H) 7.27 (d, J=8.20 Hz, 2H) 7.81 (d, J=8.20 Hz, 2 H).